HRMY logo

HRMY Cash From Financing

Annual CFF:

-$11.00M+$94.56M(+89.58%)
December 31, 2024

Summary

  • As of today, HRMY annual cash from financing is -$11.00 million, with the most recent change of +$94.56 million (+89.58%) on December 31, 2024.
  • During the last 3 years, HRMY annual cash from financing has fallen by -$18.41 million (-248.21%).
  • HRMY annual cash from financing is now -105.26% below its all-time high of $209.16 million, reached on December 31, 2020.

Performance

HRMY Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

Quarterly CFF:

-$3.00M-$310.00K(-11.54%)
September 30, 2025

Summary

  • As of today, HRMY quarterly cash from financing is -$3.00 million, with the most recent change of -$310.00 thousand (-11.54%) on September 30, 2025.
  • Over the past year, HRMY quarterly cash from financing has dropped by -$1.82 million (-154.98%).
  • HRMY quarterly cash from financing is now -102.19% below its all-time high of $136.62 million, reached on September 30, 2020.

Performance

HRMY Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

TTM CFF:

-$8.78M-$1.82M(-26.19%)
September 30, 2025

Summary

  • As of today, HRMY TTM cash from financing is -$8.78 million, with the most recent change of -$1.82 million (-26.19%) on September 30, 2025.
  • Over the past year, HRMY TTM cash from financing has increased by +$53.00 million (+85.80%).
  • HRMY TTM cash from financing is now -104.17% below its all-time high of $210.32 million, reached on September 30, 2020.

Performance

HRMY TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HRMY Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+89.6%-155.0%+85.8%
3Y3 Years-248.2%-246.2%-178.0%
5Y5 Years-107.7%-102.2%-104.2%

HRMY Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-248.2%+89.6%-187.9%+94.6%-178.0%+92.4%
5Y5-Year-105.3%+89.6%-102.2%+94.6%-104.2%+92.4%
All-TimeAll-Time-105.3%+89.6%-102.2%+94.6%-104.2%+92.4%

HRMY Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$3.00M(-11.5%)
-$8.78M(-26.2%)
Jun 2025
-
-$2.69M(-663.1%)
-$6.95M(+9.9%)
Mar 2025
-
-$352.00K(+87.2%)
-$7.71M(+29.8%)
Dec 2024
-$11.00M(+89.6%)
-$2.74M(-133.3%)
-$11.00M(+82.2%)
Sep 2024
-
-$1.18M(+65.9%)
-$61.78M(+46.6%)
Jun 2024
-
-$3.45M(+5.2%)
-$115.70M(-2.8%)
Mar 2024
-
-$3.63M(+93.2%)
-$112.59M(-6.7%)
Dec 2023
-$105.55M(-1642.9%)
-$53.52M(+2.9%)
-$105.55M(-113.8%)
Sep 2023
-
-$55.10M(>-9900.0%)
-$49.37M(-734.8%)
Jun 2023
-
-$339.00K(-109.9%)
$7.78M(-12.3%)
Mar 2023
-
$3.41M(+28.3%)
$8.87M(+29.6%)
Dec 2022
$6.84M
$2.66M(+29.7%)
$6.84M(-39.2%)
Sep 2022
-
$2.05M(+173.3%)
$11.26M(+26.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
$750.00K(-45.8%)
$8.89M(+1.2%)
Mar 2022
-
$1.38M(-80.4%)
$8.79M(+18.5%)
Dec 2021
$7.42M(-96.5%)
$7.07M(+2359.4%)
$7.42M(+1017.1%)
Sep 2021
-
-$313.00K(-148.3%)
-$809.00K(-100.6%)
Jun 2021
-
$648.00K(+5300.0%)
$136.13M(+0.5%)
Mar 2021
-
$12.00K(+101.0%)
$135.41M(-35.3%)
Dec 2020
$209.16M(+45.5%)
-$1.16M(-100.8%)
$209.16M(-0.5%)
Sep 2020
-
$136.62M(>+9900.0%)
$210.32M(+185.4%)
Jun 2020
-
-$67.00K(-100.1%)
$73.69M(-41.6%)
Mar 2020
-
$73.76M(+40.6%)
$126.24M(+78.6%)
Dec 2019
$143.77M(+565.1%)
-
-
Jun 2019
-
$52.48M(+188.1%)
$70.69M(+288.1%)
Mar 2019
-
$18.22M
$18.22M
Dec 2018
$21.61M
-
-

FAQ

  • What is Harmony Biosciences Holdings, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. annual cash from financing year-on-year change?
  • What is Harmony Biosciences Holdings, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. quarterly cash from financing year-on-year change?
  • What is Harmony Biosciences Holdings, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. TTM cash from financing year-on-year change?

What is Harmony Biosciences Holdings, Inc. annual cash from financing?

The current annual cash from financing of HRMY is -$11.00M

What is the all-time high annual cash from financing for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high annual cash from financing is $209.16M

What is Harmony Biosciences Holdings, Inc. annual cash from financing year-on-year change?

Over the past year, HRMY annual cash from financing has changed by +$94.56M (+89.58%)

What is Harmony Biosciences Holdings, Inc. quarterly cash from financing?

The current quarterly cash from financing of HRMY is -$3.00M

What is the all-time high quarterly cash from financing for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high quarterly cash from financing is $136.62M

What is Harmony Biosciences Holdings, Inc. quarterly cash from financing year-on-year change?

Over the past year, HRMY quarterly cash from financing has changed by -$1.82M (-154.98%)

What is Harmony Biosciences Holdings, Inc. TTM cash from financing?

The current TTM cash from financing of HRMY is -$8.78M

What is the all-time high TTM cash from financing for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high TTM cash from financing is $210.32M

What is Harmony Biosciences Holdings, Inc. TTM cash from financing year-on-year change?

Over the past year, HRMY TTM cash from financing has changed by +$53.00M (+85.80%)
On this page